American Shared Hospital Services EBITDA Margin 2010-2024 | AMS
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for American Shared Hospital Services (AMS) over the last 10 years. The current EBITDA margin for American Shared Hospital Services as of December 31, 2024 is .
| American Shared Hospital Services EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2024-12-31 | $0.03B | $0.01B | 17.86% |
| 2024-09-30 | $0.03B | $0.01B | 28.00% |
| 2024-06-30 | $0.02B | $0.01B | 34.78% |
| 2024-03-31 | $0.02B | $0.01B | 31.82% |
| 2023-12-31 | $0.02B | $0.01B | 31.82% |
| 2023-09-30 | $0.02B | $0.01B | 33.33% |
| 2023-06-30 | $0.02B | $0.01B | 33.33% |
| 2023-03-31 | $0.02B | $0.01B | 40.00% |
| 2022-12-31 | $0.02B | $0.01B | 40.00% |
| 2022-09-30 | $0.02B | $0.01B | 40.00% |
| 2022-06-30 | $0.02B | $0.01B | 42.11% |
| 2022-03-31 | $0.02B | $0.01B | 44.44% |
| 2021-12-31 | $0.02B | $0.01B | 47.06% |
| 2021-09-30 | $0.02B | $0.00B | -5.88% |
| 2021-06-30 | $0.02B | $0.00B | -5.56% |
| 2021-03-31 | $0.02B | $0.00B | -11.11% |
| 2020-12-31 | $0.02B | $0.00B | -10.53% |
| 2020-09-30 | $0.02B | $0.01B | 36.84% |
| 2020-06-30 | $0.02B | $0.01B | 42.11% |
| 2020-03-31 | $0.02B | $0.01B | 50.00% |
| 2019-12-31 | $0.02B | $0.01B | 55.00% |
| 2019-09-30 | $0.02B | $0.01B | 55.00% |
| 2019-06-30 | $0.02B | $0.01B | 52.63% |
| 2019-03-31 | $0.02B | $0.01B | 52.63% |
| 2018-12-31 | $0.02B | $0.01B | 52.63% |
| 2018-09-30 | $0.02B | $0.01B | 57.89% |
| 2018-06-30 | $0.02B | $0.01B | 60.00% |
| 2018-03-31 | $0.02B | $0.01B | 60.00% |
| 2017-12-31 | $0.02B | $0.01B | 60.00% |
| 2017-09-30 | $0.02B | $0.01B | 60.00% |
| 2017-06-30 | $0.02B | $0.01B | 60.00% |
| 2017-03-31 | $0.02B | $0.01B | 60.00% |
| 2016-12-31 | $0.02B | $0.01B | 57.89% |
| 2016-09-30 | $0.02B | $0.01B | 61.11% |
| 2016-06-30 | $0.02B | $0.01B | 58.82% |
| 2016-03-31 | $0.02B | $0.01B | 56.25% |
| 2015-12-31 | $0.02B | $0.01B | 56.25% |
| 2015-09-30 | $0.02B | $0.01B | 50.00% |
| 2015-06-30 | $0.02B | $0.01B | 50.00% |
| 2015-03-31 | $0.02B | $0.01B | 53.33% |
| 2014-12-31 | $0.02B | $0.01B | 53.33% |
| 2014-09-30 | $0.02B | $0.01B | 53.33% |
| 2014-06-30 | $0.02B | $0.01B | 53.33% |
| 2014-03-31 | $0.02B | $0.01B | 47.06% |
| 2013-12-31 | $0.02B | $0.01B | 44.44% |
| 2013-09-30 | $0.02B | $0.01B | 44.44% |
| 2013-06-30 | $0.02B | $0.01B | 44.44% |
| 2013-03-31 | $0.02B | $0.01B | 47.06% |
| 2012-12-31 | $0.02B | $0.01B | 50.00% |
| 2012-09-30 | $0.02B | $0.01B | 52.94% |
| 2012-06-30 | $0.02B | $0.01B | 45.45% |
| 2012-03-31 | $0.02B | $0.01B | 45.45% |
| 2011-12-31 | $0.02B | $0.01B | 45.45% |
| 2011-09-30 | $0.02B | $0.01B | 42.86% |
| 2011-06-30 | $0.02B | $0.01B | 50.00% |
| 2011-03-31 | $0.02B | $0.01B | 50.00% |
| 2010-12-31 | $0.02B | $0.01B | 50.00% |
| 2010-09-30 | $0.02B | $0.01B | 50.00% |
| 2010-06-30 | $0.02B | $0.01B | 50.00% |
| 2010-03-31 | $0.02B | $0.01B | 47.06% |
| 2009-12-31 | $0.02B | $0.01B | 47.06% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.018B | $0.028B |
| American Shared Hospital Services provides turnkey technology solutions for advanced radiosurgical and radiation therapy services. AMS is the world leader in providing Gamma Knife radiosurgery services, a non-invasive treatment for malignant and benign brain tumors, vascular malformations and trigeminal neuralgia . The Company also offers the latest IGRT and IMRT systems, as well as its proprietary Operating Room for the twenty first Century concept. Through its equity investment in Still River Systems, AMS also plans to complement these services with the Clinatron-two hundred fifty, proton beam radiation therapy system, which has not yet been approved by the FDA. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $192.295B | 84.22 |
| Thermo Fisher Scientific (TMO) | United States | $152.179B | 18.41 |
| Alcon (ALC) | Switzerland | $47.228B | 31.39 |
| Edwards Lifesciences (EW) | United States | $43.221B | 28.34 |
| IDEXX Laboratories (IDXX) | United States | $39.543B | 45.44 |
| DexCom (DXCM) | United States | $33.200B | 51.31 |
| IQVIA Holdings (IQV) | United States | $25.775B | 14.44 |
| Mettler-Toledo (MTD) | United States | $22.466B | 26.72 |
| STERIS (STE) | Ireland | $22.247B | 25.44 |
| Waters (WAT) | United States | $20.475B | 28.89 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.744B | 0.00 |
| Hologic (HOLX) | United States | $12.646B | 13.74 |
| Penumbra (PEN) | United States | $11.514B | 90.37 |
| Sysmex ADR (SSMXY) | Japan | $11.482B | 0.00 |
| Masimo (MASI) | United States | $8.489B | 31.31 |
| Globus Medical (GMED) | United States | $7.678B | 18.01 |
| Teleflex (TFX) | United States | $5.528B | 9.13 |
| Glaukos (GKOS) | United States | $5.140B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.133B | 21.65 |
| TransMedics (TMDX) | United States | $3.771B | 81.99 |
| PROCEPT BioRobotics (PRCT) | United States | $2.939B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.402B | 14.31 |
| Veracyte (VCYT) | United States | $2.327B | 32.65 |
| Nihon Kohden (NHNKY) | Japan | $2.040B | 11.15 |
| Elekta AB (EKTAY) | Sweden | $1.943B | 17.47 |
| Alphatec Holdings (ATEC) | United States | $1.785B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.531B | 0.00 |
| Artivion (AORT) | United States | $1.235B | 115.64 |
| Pulse Biosciences (PLSE) | United States | $1.148B | 0.00 |
| OPKO Health (OPK) | United States | $0.983B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.952B | 5.06 |
| SiBone (SIBN) | United States | $0.788B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.673B | 14.71 |
| IRadimed (IRMD) | United States | $0.659B | 33.46 |
| Beta Bionics (BBNX) | United States | $0.605B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.585B | 9.10 |
| OrthoPediatrics (KIDS) | United States | $0.535B | 0.00 |
| RxSight (RXST) | United States | $0.531B | 0.00 |
| AxoGen (AXGN) | United States | $0.518B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.517B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.473B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.429B | 0.00 |
| NeuroPace (NPCE) | United States | $0.422B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.395B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.370B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.336B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.334B | 7.09 |
| Neuronetics (STIM) | United States | $0.292B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.222B | 13.44 |
| Alpha Tau Medical (DRTS) | Israel | $0.208B | 0.00 |
| 908 Devices (MASS) | United States | $0.201B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.177B | 0.00 |
| Inogen (INGN) | United States | $0.168B | 0.00 |
| LENSAR (LNSR) | United States | $0.164B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.159B | 0.00 |
| Accuray (ARAY) | United States | $0.156B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.152B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.145B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.133B | 0.00 |
| CVRx (CVRX) | United States | $0.124B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.119B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.105B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.094B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.088B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.082B | 0.00 |
| InspireMD (NSPR) | Israel | $0.080B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.074B | 11.23 |
| EnVVeno Medical (NVNO) | United States | $0.064B | 0.00 |
| Hyperfine (HYPR) | United States | $0.058B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.052B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.051B | 15.64 |
| Vicarious Surgical (RBOT) | United States | $0.051B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.047B | 0.00 |
| Envoy Medical (COCH) | United States | $0.036B | 0.00 |
| Precision Optics (POCI) | United States | $0.035B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.034B | 0.00 | |
| Spectral AI (MDAI) | United States | $0.031B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.022B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.008B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.22 |